Stoke Therapeutics Inc’s recent filing unveils that its 10% Owner Skorpios Trust unloaded Company’s shares for reported $23.0 million on Dec 23 ’24. In the deal valued at $11.50 per share,2,000,000 shares were sold. As a result of this transaction, Skorpios Trust now holds 6,906,181 shares worth roughly $74.59 million.
Then, Blue Horizon Enterprise Ltd bought 2,000,000 shares, generating $23,180,000 in total proceeds.
Before that, Ticho Barry sold 2,586 shares. Stoke Therapeutics Inc shares valued at $33,596 were divested by the CHIEF MEDICAL OFFICER at a price of $12.99 per share. As a result of the transaction, Ticho Barry now holds 44,746 shares, worth roughly $0.48 million.
Chardan Capital Markets initiated its Stoke Therapeutics Inc [STOK] rating to a Buy in a research note published on December 20, 2024; the price target was $24. TD Cowen also remained covering STOK and has increased its forecast on March 26, 2024 with a “an Outperform” recommendation from previously “Market perform” rating.
Price Performance Review of STOK
On Monday, Stoke Therapeutics Inc [NASDAQ:STOK] saw its stock fall -2.35% to $10.80. Over the last five days, the stock has lost -7.53%. Stoke Therapeutics Inc shares have risen nearly 105.32% since the year began. Nevertheless, the stocks have risen 100.00% over the past one year. While a 52-week high of $17.58 was reached on 06/13/24, a 52-week low of $4.09 was recorded on 02/13/24. SMA at 50 days reached $12.33, while 200 days put it at $13.07.
Levels Of Support And Resistance For STOK Stock
The 24-hour chart illustrates a support level at 10.52, which if violated will result in even more drops to 10.25. On the upside, there is a resistance level at 11.08. A further resistance level may holdings at 11.37. The Relative Strength Index (RSI) on the 14-day chart is 36.68, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.76, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.00%. Stochastics %K at 11.87% indicates the stock is a buying.
How much short interest is there in Stoke Therapeutics Inc?
A steep rise in short interest was recorded in Stoke Therapeutics Inc stocks on 2024-12-13, growing by 0.85 million shares to a total of 7.26 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 6.4 million shares. There was a rise of 11.75%, which implies that there is a positive sentiment for the stock.
